CCXI Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 spal. 2022 @ 23:00):

Stats
Šios dienos apimtis	656 224
Vidutinė apimtis	2.02M
Rinkos kapitalizacija	0.00
EPS	$-0.450 ( Q2 \| 2022-08-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-25.93 (Sector) 42.63 (Industry) 24.32
ATR14	$0.378 (0.73%)

AADI 0.00%

ABCL 0.98%

ABCM 0.04%

ABEO 0.22%

ABIO 2.17%

ABOS -0.40%

ABSI -0.15%

ABUS 0.33%

ABVX -0.22%

ACAD 0.54%

ACER -17.95%

ACET 0.38%

ACGN 1.29%

ACHL -2.44%

ACHV 1.63%

ACIU 0.00%

ACLX 0.28%

ACRV 0.73%

ACST 0.62%

ACXP 1.68%

ADAG -5.64%

ADAP -1.27%

ADGI 0.87%

ADIL -1.57%

ADMA 0.24%

ADPT -0.96%

ADTX -1.27%

ADVM -0.07%

ADXN -6.11%

AEON 11.51%

AEZS -5.44%

AFMD -0.59%

AGEN -1.89%

AGIO 0.56%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 53.45%

AKBA -0.95%

AKRO 0.26%

AKTX -2.70%

AKUS 0.00%

ALBO 0.00%

ALDX 3.34%

ALEC 0.44%

ALGS -0.25%

ALKS 0.34%

ALLK -0.85%

ALLO -0.87%

ALLR -2.32%

ALNA 3.16%

ALNY -0.01%

ALPN 0.00%

ALPX 0.00%

ALRN -0.31%

ALT -0.34%

ALVR 0.60%

ALXN 0.00%

ALXO -1.49%

ALZN 0.00%

AMRN -0.52%

AMTI -3.13%

ANAB -0.94%

ANEB -5.58%

ANGN 0.00%

ANIX -1.15%

ANL 0.61%

ANNX -0.65%

ANPC -3.15%

APGE 0.36%

APGN 8.48%

APGNW 30.65%

APLM 10.18%

APLS 0.78%

APLT 0.21%

APM 1.33%

APOP 0.38%

APRE 2.44%

APTO 0.68%

APTX 3.17%

APVO -0.02%

ARAV -13.39%

ARCT -0.44%

ARDS 20.48%

ARDX 0.00%

ARGX 0.19%

ARNA 0.00%

ARPO -0.90%

ARQT -1.51%

ARTL -4.55%

ARTLW 9.80%

ARVN -0.60%

ARWR -0.24%

ASLN 2.75%

ASMB -0.86%

ASND 0.41%

ATAI 0.37%

ATHA -0.38%

ATHE -1.61%

ATHX -33.50%

ATNF -4.37%

ATOS 0.87%

ATRA -2.10%

ATXI -1.66%

ATXS 0.45%

AUPH -0.36%

AURA 0.68%

AUTL -0.23%

AVBP -0.27%

AVEO 0.00%

AVIR -0.28%

AVRO -2.05%

AVTE -4.51%

AVTX 4.15%

AVXL 0.00%

AXLA 0.00%

AXSM 0.07%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.44%

BCAB 1.92%

BCDA -0.30%

BCDAW -33.33%

BCEL -1.32%

BCLI 1.23%

BCRX -1.03%

BCTX -0.68%

BCTXW 0.00%

BCYC 1.49%

BDRX 1.05%

BDTX -0.55%

BEAM -0.12%

BFRA -2.91%

BGNE -1.47%

BIOR 0.03%

BIVI 1.73%

BLCM -6.68%

BLI -5.88%

BLPH -0.79%

BLRX 2.36%

BLTE -0.72%

BLU 0.03%

BLUE -0.61%

BMEA -0.39%

BMRN 0.19%

BNOX 10.76%

BNTC 2.46%

BNTX -0.16%

BOLD 0.49%

BOLT -0.50%

BPMC 0.12%

BPTH 1.26%

BPTS -13.47%

BRNS 2.96%

BRTX -8.88%

BTAI 0.75%

BTTX -7.50%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 0.00%

CABA -1.41%

CADL -1.11%

CALA 60.00%

CALC -1.62%

CALT -0.64%

CAPR -0.60%

CARA 2.85%

CARM 0.97%

CASI -2.41%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 2.61%

CCCC -1.09%

CCXI 0.00%

CDAK 0.00%

CDIO -3.01%

CDIOW 0.00%

CDMO -0.40%

CDMOP 0.04%

CDT -6.11%

CDTTW 294.32%

CDTX -0.08%

CDXC -1.18%

CDXS -1.51%

CELC 0.99%

CELU 7.05%

CELUW -9.52%

CERC -1.68%

CERE 0.07%

CERO -4.29%

CEROW -44.78%

CFRX -27.95%

CGEM -1.87%

CGEN -1.02%

CGON 0.00%

CGTX 1.37%

CHMA -6.00%

CHRS -0.01%

CINC 0.00%

CING 4.48%

CINGW -48.24%

CKPT -0.49%

CLBS -16.75%

CLDX 2.83%

CLGN 0.30%

CLLS -6.54%

CLNN 0.37%

CLNNW -41.25%

CLRB 0.74%

CLSD 0.86%

CLSN -0.68%

CLVS 0.00%

CMMB 10.18%

CMND 3.65%

CMPI 0.00%

CMPX 0.00%

CMRA 0.40%

CMRAW 33.33%

CMRX 1.11%

CNCE 0.00%

CNSP -1.73%

CNST 0.00%

CNTA 0.31%

CNTB 3.13%

CNTX -1.03%

COCP 0.42%

COEPW -0.66%

COGT -0.11%

CORT -0.28%

COYA 2.22%

CPRX 0.00%

CRBP -2.67%

CRBU -0.57%

CRDF -0.75%

CRGX 0.00%

CRIS 0.73%

CRNX -0.16%

CRSP 0.14%

CRTX 2.63%

CRVO 1.97%

CRVS 0.00%

CSBR 1.19%

CTCX -8.04%

CTIC 0.06%

CTMX 3.65%

CTNM -2.94%

CTXR 1.43%

CUE -0.75%

CVAC 0.86%

CVKD 1.37%

CWBR -2.55%

CYAD -12.96%

CYCC -2.45%

CYCCP -1.79%

CYCN 6.00%

CYT -2.27%

CYTK -0.13%

CYTO -3.23%

DARE 1.19%

DAWN 0.54%

DBTX -0.81%

DBVT 1.01%

DFFN 10.28%

DICE 0.06%

DMAC -0.42%

DNLI 1.12%

DNTH 0.04%

DOMH 1.99%

DRMA 0.00%

DRMAW 0.00%

DRNA 0.00%

DRTS -1.32%

DRTSW 1.01%

DRUG 0.00%

DSGN 0.26%

DTIL -1.19%

DYAI -5.29%

EARS -1.77%

EDIT 3.55%

EDSA 1.04%

EFTR -3.13%

EFTRW -0.26%

EIGR 0.00%

ELAB -2.87%

ELDN 0.71%

ELEV -0.84%

ELOX -12.50%

ELTX -2.33%

ELVN -0.65%

ELYM 0.52%

ENGN -3.89%

ENGNW -5.29%

ENLV 0.73%

ENOB 1.79%

ENSC 0.88%

ENTA -0.75%

ENTO 0.48%

ENTX 1.45%

ENVB 3.24%

EPIX 0.00%

EPRX -0.19%

EPZM 0.00%

EQ 1.40%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.49%

ERNA 4.79%

ERYP 1.30%

ESLA 1.14%

ESLAW -9.25%

ETNB 0.63%

ETON 1.19%

ETTX 0.00%

EVAX 4.45%

EVGN -2.55%

EVLO 50.00%

EWTX -0.58%

EXAI -0.20%

EXEL -0.30%

EYEG -0.43%

EYEN -0.33%

EYPT -1.33%

FATE 0.42%

FBIO 0.21%

FBIOP 1.09%

FBLG -1.17%

FBRX -7.46%

FDMT -0.67%

FENC 0.74%

FGEN 0.47%

FHTX 9.52%

FIXX 0.77%

FMTX 0.00%

FNCH -6.25%

FOLD -0.30%

FREQ 4.76%

FRLN 0.15%

FRTX -0.54%

FSTX 0.00%

FTRE 0.58%

FULC 0.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.20%

GANX -0.76%

GBIO 1.37%

GBT 0.01%

GDTC -7.21%

GERN -0.96%

GHRS 3.42%

GLMD -3.30%

GLPG 0.93%

GLSI -1.83%

GLTO 0.00%

GLUE 0.00%

GLYC 2.57%

GMAB 0.95%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 0.97%

GNLX 0.00%

GNPX 1.84%

GNTA 0.00%

GOSS 13.19%

GOVX 18.92%

GOVXW -24.72%

GPCR 0.93%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -1.42%

GRTX -4.26%

GTHX 0.38%

GUTS 0.28%

GXGXW 41.67%

GYRE 0.17%

HALO -0.01%

HARP 0.09%

HCWB -9.73%

HEPA -6.36%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 0.56%

HOTH -3.73%

HOWL -1.27%

HRMY 0.00%

HRTX 1.66%

HSTO 62.16%

HUMA 0.65%

HUMAW -5.97%

IBRX 1.12%

ICCC 2.84%

ICPT 0.21%

ICU -0.26%

ICUCW -10.39%

ICVX -0.91%

IDRA -23.04%

IDYA -0.13%

IFRX -3.21%

IGMS 0.14%

IKNA 1.15%

IKT 8.90%

IMAB -1.10%

IMCR -1.45%

IMGN 0.02%

IMGO 0.00%

IMMP -1.49%

IMMX -0.49%

IMNM -0.99%

IMNN -0.90%

IMPL -27.27%

IMRA 15.96%

IMRN -2.78%

IMRX 0.32%

IMTX -0.85%

IMTXW -2.70%

IMUX 1.75%

IMV 0.00%

IMVT 0.11%

INAB -0.02%

INBX -0.35%

INCY 0.18%

INDP -3.03%

INFI -52.38%

INKT -0.39%

INM 1.46%

INMB -0.60%

INO 0.00%

INSM -0.40%

INTS 0.84%

INVA 1.55%

INZY 0.44%

IOBT -0.81%

IONS -0.37%

IOVA -0.20%

IPA 0.00%

IPHA -10.64%

IPSC 0.95%

IRON -1.08%

ISEE 0.38%

ITOS -0.84%

ITRM -2.61%

IVA 2.64%

IVVD 0.00%

JAGX -0.26%

JANX 0.17%

JAZZ 0.06%

JNCE 0.00%

JSPR -0.08%

JSPRW 2.33%

JUNS 0.00%

JUNSW 0%

KA -5.56%

KALV -0.42%

KDNY 0.22%

KMPH -0.34%

KNSA -0.05%

KNTE -0.38%

KOD 0.00%

KPRX 8.51%

KPTI -0.28%

KRBP 4.17%

KRON 0.00%

KROS -1.56%

KRRO -0.63%

KRTX 0.03%

KRYS -0.18%

KTRA 9.27%

KTTA -2.85%

KTTAW 8.62%

KURA 1.02%

KYMR -0.38%

KYTX -0.25%

KZIA 8.44%

KZR 0.65%

LABP 0.57%

LBPH -0.98%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.19%

LENZ -1.30%

LEXX 2.73%

LEXXW -9.42%

LGND -0.46%

LGNDV 0.00%

LGVN -12.50%

LIAN 0.00%

LIFE 2.70%

LIPO -1.23%

LIXT 0.40%

LIXTW 27.74%

LJPC -0.32%

LMNL 0.12%

LOGC -0.72%

LPCN 2.99%

LPTX -0.25%

LQDA -0.23%

LRMR 1.19%

LSTA -4.97%

LTRN -2.24%

LUMO 0.00%

LVTX -1.42%

LXEO -1.05%

LXRX 0.87%

LYEL -0.45%

LYRA -1.26%

MACK 0.00%

MBIO 34.00%

MBRX -4.83%

MCRB -0.88%

MDGL 0.06%

MDNA -13.16%

MDWD 1.00%

MDXG 0.15%

MEIP 1.41%

MESO 2.07%

MGNX -2.46%

MGTA -7.74%

MGTX -1.14%

MGX 2.85%

MIRM 1.20%

MIRO 0.59%

MIST 2.96%

MITO 0.00%

MLEC -4.55%

MLECW 9.25%

MLND -5.36%

MLTX 0.09%

MLYS -0.66%

MNKD 0.00%

MNMD 1.14%

MNOV 0.00%

MNPR 3.39%

MOLN 2.88%

MOR -0.55%

MORF 1.34%

MREO 0.00%

MRKR -4.76%

MRNA -1.04%

MRNS 2.07%

MRSN 0.00%

MRTX -0.17%

MRUS -1.24%

MRVI 0.28%

MTCR -1.29%

MTEM 1.54%

MTP -18.50%

MURA -0.30%

MYMD -0.91%

NAMS 3.25%

NAMSW -7.61%

NAUT 1.17%

NBRV 0.71%

NBSE -1.56%

NBTX -6.05%

NCNA -1.64%

NERV 0.00%

NEXI -1.40%

NGM -1.28%

NGNE -3.95%

NKGN 0.78%

NKGNW 39.76%

NKTR -2.14%

NKTX -1.23%

NLSP 139.01%

NLSPW 6.21%

NMRA 1.29%

NMTR -42.97%

NOVN -24.84%

NRBO 0.45%

NRIX 4.28%

NRSN -4.95%

NRSNW 6.50%

NRXP 0.99%

NRXPW -15.65%

NRXS -6.06%

NTBL 2.92%

NTEC -12.45%

NTHI 0%

NTLA 0.00%

NTRBW -6.25%

NUVL -0.03%

NVAX -1.21%

NVCT 1.18%

NVIV -34.28%

NXTC 0.70%

NYMX -0.05%

OABI -0.47%

OABIW 13.46%

OBIO -0.87%

OBSV 0.00%

OCEA -3.21%

OCGN 2.61%

OCS -1.09%

OCUL -1.18%

OCUP 0.00%

ODT -4.27%

OKYO 0.00%

OLMA -0.47%

OMER 0.87%

OMGA 5.65%

ONCO 13.41%

ONCR -3.08%

ONCS 31.87%

ONCT -0.12%

ONCY -0.99%

ONTX -0.47%

ONVO -2.35%

OPNT 0.00%

OPT 0.80%

ORGS -1.72%

ORIC -0.13%

ORMP 0.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.26%

OVID -3.75%

OYST 0.00%

PALI 0.86%

PASG -0.99%

PBLA 9.76%

PBM -0.02%

PBYI -0.63%

PCSA 5.71%

PCVX 0.10%

PDSB -0.37%

PEPG 0.70%

PGEN 0.61%

PHAR 2.17%

PHAS 0.00%

PHAT -0.60%

PHIO 6.80%

PHIOW 36.47%

PHVS -0.53%

PHXM -5.20%

PIRS -5.64%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.27%

PLUR 0.00%

PMN 0.00%

PMVP 0.00%

PNT 0.16%

PPBT 2.78%

PRAX 5.56%

PRDS 0.93%

PRLD 0.77%

PROG -3.47%

PROK 1.03%

PRQR -2.13%

PRTA 0.34%

PRTC -0.72%

PRTG 6.52%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 0.00%

PSTX 1.81%

PTCT 0.06%

PTE -0.82%

PTGX 0.03%

PTIXW 2.50%

PULM 3.72%

PXMD -1.92%

PYPD -0.36%

PYXS 0.00%

QLGN 18.57%

QNCX -1.41%

QNRX 3.04%

QSI 0.75%

QSIAW 0.00%

QTTB 0.00%

QURE -0.75%

RAIN -1.63%

RANI 0.00%

RAPT -0.30%

RARE -0.28%

RCKT 0.19%

REGN 0.06%

RENB -1.89%

REPL -0.13%

RETA 0.02%

REUN -0.89%

REVB 5.40%

REVBU 3.46%

REVBW 25.20%

RGLS 0.42%

RGNX 1.12%

RIGL 2.00%

RLAY 1.28%

RLMD 0.00%

RLYB 0.00%

RNA -0.84%

RNAC -1.07%

RNAZ 0.00%

RNXT 0.45%

ROIV 0.37%

ROIVW 4.56%

RPHM -0.60%

RPRX 0.15%

RPTX 1.58%

RUBY 2.70%

RVLP -32.05%

RVMD -0.16%

RVMDW -23.93%

RVNC 0.36%

RVPH -0.68%

RVPHW 11.54%

RXDX 0.09%

RXRX -0.74%

RYTM 0.46%

RYZB 0.02%

RZLT 0.00%

SABS -2.75%

SABSW -32.14%

SAGE 0.71%

SANA -0.17%

SAVA -0.80%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -10.34%

SCPH 0.00%

SCPS 0.00%

SEEL -1.16%

SEER -0.58%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 1.55%

SGMT -0.47%

SGTX -2.56%

SIOX 22.63%

SLDB -0.40%

SLGL -2.22%

SLN -1.55%

SLNO 0.38%

SLRX 5.16%

SLS -3.04%

SMMT -0.31%

SNDX 0.13%

SNGX 0.79%

SNPX -3.97%

SONN -4.75%

SPPI -0.49%

SPRB 0.49%

SPRC -2.02%

SPRO 3.13%

SRNE 20.00%

SRPT 0.55%

SRRA 0.00%

SRRK -0.34%

SRZN -1.70%

STAB 0.00%

STOK -0.26%

STRO 0.94%

STSA 0.00%

STTK 0.40%

SURF -0.93%

SVRA -0.78%

SWTX -1.74%

SYBX -0.63%

SYRS -2.63%

TALS -0.73%

TARA 0.41%

TARS 1.72%

TBPH -0.12%

TCBP 1.78%

TCDA 0.00%

TCON -1.47%

TCRR 0.00%

TCRT -3.13%

TCRX -1.21%

TECH 0.07%

TENX -3.43%

TERN 0.13%

TFFP -2.05%

TGTX 0.21%

THRX 0.12%

TIL -2.06%

TLC 0.00%

TLSA 0.66%

TNGX 0.59%

TNXP 0.00%

TNYA 0.00%

TPST 0.52%

TRDA -3.61%

TRVI -0.18%

TRVN -1.88%

TSHA -10.17%

TSVT 0.25%

TTNP 1.45%

TVTX -0.27%

TYRA -0.39%

UBX 0.72%

UNCY -0.11%

URGN -7.00%

UTHR 0.08%

VACC 11.36%

VALN -2.51%

VAXX -0.11%

VBIV 1.15%

VBLT -8.77%

VCEL 0.50%

VCNX -1.54%

VCYT -0.09%

VERA -0.08%

VERU 0.50%

VERV -1.33%

VIGL -2.75%

VINC 1.05%

VIR -0.87%

VIRI -5.41%

VIRX -6.84%

VKTX -0.50%

VLON -13.04%

VNDA 0.63%

VOR 0.85%

VRCA 0.00%

VRDN -0.74%

VRNA 0.51%

VRPX -12.13%

VRTX 0.03%

VSTM 0.29%

VTGN 1.46%

VTVT -0.10%

VTYX -0.36%

VXRT 7.01%

VYGR 0.10%

VYNE 2.16%

VYNT 7.78%

WINT 5.59%

WVE -0.67%

XBIO 6.75%

XBIT -0.66%

XCUR -0.65%

XENE 0.30%

XERS 0.53%

XFOR -0.54%

XLO 2.96%

XLRN 0.00%

XNCR -0.41%

XOMA 0.00%

XOMAO -0.56%

XOMAP -0.14%

XRTX 2.88%

YMAB -0.38%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.20%

ZNTL -25.39%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-10-20	Jain Rita	Sell	11 600	Restricted Stock Unit
2022-10-20	Herron Jennifer Lyn	Sell	17 237	Common Stock
2022-10-20	Edwards Thomas A.	Sell	15 723	Restricted Stock Unit
2022-10-20	Parker Geoffrey M.	Sell	15 723	Restricted Stock Unit
2022-10-20	Kanaya Susan M	Sell	90 968	Restricted Stock Unit

INSIDER POWER
-76.08
Last 97 transactions
Buy: 1 451 999 \| Sell: 1 420 462

Tūris Koreliacija

Ilgas: 0.21 (neutral)

Trumpas: 0.67 (moderate)

Signal:(79.007) Neutral

ChemoCentryx, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
SANB	0.835

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

ChemoCentryx, Inc. Koreliacija - Valiuta/Žaliavos

-0.84
( strong negative )

-0.82
( strong negative )

0.54
( weak )

-0.06
( neutral )

-0.36
( neutral )

0.79
( moderate )

ChemoCentryx, Inc. Finansinės ataskaitos

Annual	2021
Pajamos:	$32.22M
Bruto pelnas:	$31.92M (99.06 %)
EPS:	$-1.890

FY	2021
Pajamos:	$32.22M
Bruto pelnas:	$31.92M (99.06 %)
EPS:	$-1.890

FY	2020
Pajamos:	$64.89M
Bruto pelnas:	$64.89M (100.00 %)
EPS:	$-0.840

FY	2019
Pajamos:	$35.95M
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-0.980

Financial Reports:

No articles found.

ChemoCentryx, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ChemoCentryx, Inc.

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.